Synthesis of 4-Aryl-1H-1,2,3-triazoles
through TBAF-Catalyzed [3 + 2]
gen 1,3-dipolar cycloaddition of azides with alkynes. The
efficiency of this process is generally related to the
10
presence of an electron-withdrawing group on the alkyne
Cycloaddition of 2-Aryl-1-nitroethenes with
and/or on the azide.1
1,12
Recently, significant progress in
TMSN under Solvent-Free Conditions
3
the synthesis of these heterocycles has been achieved by
Sharpless et al., who have defined a Click chemistry
process in which a Cu(I)-acetylenic organometallic com-
pound prepared in situ has been used as a 1,3-dipolaro-
phile either in aqueous medium13 or in organic solvent.
Recently, Sharpless et al. have also reported the use
of an alkylmagnesium bromide as 1,3-dipolarophile in dry
THF for the synthesis of 1,5-disubstituted 1,2,3-triazoles
David Amantini, Francesco Fringuelli,*
Oriana Piermatti, Ferdinando Pizzo, Ennio Zunino, and
Luigi Vaccaro*
14
CEMIN, Centro di Eccellenza Materiali Innovativi
Nanostrutturati, Dipartimento di Chimica, Universit a` di
Perugia, Via Elce di Sotto 8, I-06123 Perugia, Italy
frifra@unipg.it; luigi@unipg.it
Received April 18, 2005
15
under “Click conditions” and demonstrated that ace-
tylcholinesterase is an efficient catalyst for the reactions
of azides with acetylenic compounds.16
Alternative synthetic routes for the preparation of
1
7
1
,2,3-triazole moiety have been rarely pursued. In
particular, a very little attention has been devoted to
3+2] cycloaddition reactions of azides with electron-poor
[
18
olefins and subsequent elimination reaction (Scheme
).
The scarce application of these substrates is probably
1
due to the poor reactivity of the reactants, which require
harsh reaction conditions generally leading to unsatisfac-
TBAF-catalyzed [3 + 2] cycloaddition reactions of 2-aryl-1-
cyano- or 2-aryl-1-carbethoxy-1-nitroethenes 1 with TMSN3
under SFC allow the corresponding 4-aryl-5-cyano- or 4-aryl-
(
8) Brockunier, L. L.; Parmee, E. R.; Ok, H. O.; Candelore, M. R.;
Cascieri, M. A.; Colwell, L. F.; Deng, L.; Feeney, W. P.; Forrest, M. J.;
Hom, G. J.; MacIntyre, D. E.; Tota, L.; Wyvratt, M. J.; Fisher, M. H.;
Weber, A. E. Bioorg. Med. Chem. Lett. 2000, 10, 2111-2114.
5
-carbethoxy-1H-1,2,3-triazoles 2 to be prepared under mild
reaction conditions and with good to excellent yields (70-
0%). The proposed protocol does not require dried glassware
or inert atmosphere.
(9) Palhagen, S.; Canger, R.; Henriksen, O.; van Parys, J. A.; Riviere,
9
M. E.; Karolchyk, M. A. Epilepsy Res. 2001, 43, 115-124.
10) (a) Sheehan, J. C.; Robinson, C. A. J. Am. Chem. Soc. 1951,
3, 1207-1210. (b) Wiley, R. H.; Hussung, K. F.; Moffat, J. J. Org.
(
7
Chem 1956, 21, 190-192. (c) Kirmse, W.; Horner, L. Liebigs Ann.
Chem. 1958, 614, 1-3. (d) Tanaka, Y.; Velen, S. R.; Miller, S. I.
Tetrahedron 1973, 29, 3271-3283. (e) De Pasquale, R. J.; Padgett, C.
D.; Rosser, R. W. J. Org. Chem. 1975, 40, 810-811. (f) Abu-Orabi, S.
T.; Atfah, M. A.; Jibril, I.; Mari’i, F. M.; Fakhri, M.; Ali, A. A. J.
Heterocycl. Chem. 1989, 26, 1461-1468. (f) Journet, M.; Cai, D.; Kowal,
J. J.; Larsen, R. D. Tetrahedron Lett. 2001, 42, 9117-9118. (g)
Katritzky, A.; Singh, S. K. J. Org. Chem. 2002, 67, 9077-9079. (h)
Garanti, L.; Molteni, G. Tetrahedron Lett. 2003, 44, 1133-1135. (i)
Haryu, K.; Vahermo, M.; Mutikainen, I.; Yli-Kauhauloma, J. J. Comb.
Chem. 2003, 5, 826-833. (j) Helms, B.; Mynar, J.; Hawker, C. J.;
Fr e´ chet, J. M. J. Am. Chem. Soc. 2004, 126, 15020-15021.
1
H-1,2,3-Triazoles are heterocycles with a wide range
1
of applications that are receiving a growing attention.
They are commercially employed as anticorrosive agents,
agrochemicals, photostabilizer photographic materials,
2
4
3
4
and dyes. In addition, they constitute the essential
5
moiety of a number of drugs, and they are also potent
HIV-1 inhibitors,6 anti-microbial agents,7 as well as
8
selective â
3
-adrenergic receptor agonists. They can also
9
act as antiviral and anticonvulsant agents.
,2,3-Triazole synthesis has been intensively studied,
and 1,2,3-triazoles are commonly prepared by the Huis-
(11) (a) Huisgen, R.; Knorr, R.; M oius, L.; Szeimies, G. Chem. Ber.
1
9
1
965, 98, 4014-4021. (b) Huisgen, R.; Blaschke, H. Chem. Ber. 1965,
8, 2985-2997. (c) Woerner, F. P.; Reimlinger, H. Chem. Ber. 1970,
03, 1908-1917.
1
(
12) (a) Gold, v. H. Liebigs Ann. Chem. 1965, 688, 205-216. (b)
Winter, W.; M u¨ ller, E. Chem. Ber. 1974, 107, 715-716.
13) (a) Tornøe, C. W.; Christensen, C.; Meldal, M. J. Org. Chem.
(
1) (a) Dehne, H. In Methodenischen Chemie (Houben-Weyl); Shu-
mann, E., Ed.; Thieme: Stuttgart, 1994; Vol/ E 8d, 305-405 and 406-
78. (b) Tom e´ , A. C. Sci. Synth. 2004, 13, 415-601.
2) Morgan, N. H. (CHOMERICS, Inc.) Eur. Pat. Appl. EP 437979
A2 19910724, 1991.
3) Fan, W. In Comprehensive Heterocyclic Chemistry II; Katritzky,
A. R., Rees, C. W., Scriven, E. F. V., Eds.; Pergamon: Oxford, U.K.,
996; Vol. 4, pp 1-126.
4) Willis, R. J.; Marlow, I. D. Eur. Pat Appl. 400842, 1990; Chem.
Abstr. 1991, 114, 164247b.
5) (a) Cai, D.; Journet, M.; Larsen, R. D. US Patent US 6051707,
000.
6) (a) Alvarez, R.; Velazquez, S.; San-Felix, A.; Aquaro, S.; De
(
2
002, 67, 3037-3064. (b) Rostovstev, V.; Green, L. G.; Fokin, V. V.;
4
Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 2596-2599. (c) Chan,
T. R.; Hilgraf, R.; Sharpless, K. B.; Fokin, V. V. Org. Lett. 2004, 6,
(
2
853-2855. (d) Feldman, A. K.; Colasson, B.; Fokin, V. V. Org. Lett.
004, 6, 3897-3899. (e) Appukkuttan, P.; Dehaen, W.; Fokin, V. V.;
(
2
Van der Eycken, E. Org. Lett. 2004, 6, 4223-4225. (f) Sivakumar, K.;
Xie, F.; Cash, B. M.; Long, S.; Barnhill, H. N.; Wang, Q. Org. Lett.
2
1
(
004, 6, 4603-4606. (g) Himo, F.; Lovell, T.; Hilgraf, R.; Rosostev, V.
V.; Noodleman, L.; Sharpless, K. B.; Fokin, V. V. J. Am. Chem. Soc.
(
2
2
1
005, 127, 210-216.
14) Kamijo, S.; Jin, T.; Huo, Z.; Yamamoto, Y. J. Am. Chem. Soc.
003, 125, 7786-7787.
15) Krasinki, A.; Fokin, V. V.; Sharpless, K. B. Org. Lett. 2004, 6,
237-1240.
16) Lewis, W. G.; Green, L. G.; Grynszpan, F.; Radi e´ , Z.; Carlier,
2
(
(
Clercq, E.; Perno, C.-F.; Karlsson, A.; Balzarini, J.; Camarasa, M. J.
J. Med. Chem. 1994, 37, 4185-4194. (b) Velaquez, S.; Alvarez, R.;
Perez, C.; Gago, F.; De Clercq, E.; Balzarini, J.; Camarasa, M.-J.
Antivir. Chem. Chemother. 1998, 9, 481-489.
(
(
P. R.; Taylor, P.; Finn, M. G.; Sharpless, K. B. Angew. Chem., Int. Ed.
(7) Genin, M. J.; Allwine, D. A.; Anderson, D. J.; Barbachyn, M. R.;
2002, 41, 1053-1057.
Emmert, D. E.; Garmon, S. A.; Graber, D. R.; Grega, K. C.; Hester, J.
B.; Hutchinson, D. K.; Morris, J.; Reischer, R. J.; Ford, C. W.; Zurenko,
G. E.; Hamel, J. C.; Schaadt, R. D.; Stapert, D.; Yagi, B. H. J. Med.
Chem. 2000, 43, 953-970.
(
17) (a) Dong, Z.; Hellmund, K. A.; Pyne, S. G. Aust. J. Chem. 1993,
46, 1431-1436. (b) Batanero, D. B.; Barba, F. Heterocycles 2004, 65,
1175-1180. (c) Raghavendra, M. S.; Lam, Y. Tetrahedron Lett. 2004,
45, 6129-6132.
10.1021/jo0507845 CCC: $30.25 © 2005 American Chemical Society
6526
J. Org. Chem. 2005, 70, 6526-6529
Published on Web 07/09/2005